Spero Therapeutics Inc
NASDAQ:SPRO
Income Statement
Earnings Waterfall
Spero Therapeutics Inc
Revenue
|
103.8m
USD
|
Operating Expenses
|
-77m
USD
|
Operating Income
|
26.8m
USD
|
Other Expenses
|
-4m
USD
|
Net Income
|
22.8m
USD
|
Income Statement
Spero Therapeutics Inc
Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
+82%
|
2
+49%
|
3
+51%
|
3
+7%
|
3
+2%
|
4
+22%
|
11
+165%
|
12
+16%
|
16
+33%
|
18
+12%
|
12
-33%
|
12
-4%
|
11
-5%
|
9
-16%
|
15
+60%
|
18
+23%
|
17
-5%
|
18
+5%
|
13
-29%
|
10
-24%
|
9
-11%
|
54
+507%
|
54
N/A
|
54
+1%
|
78
+43%
|
104
+34%
|
|
Operating Income | ||||||||||||||||||||||||||||
Operating Expenses |
(35)
|
(38)
|
(44)
|
(48)
|
(48)
|
(49)
|
(47)
|
(48)
|
(54)
|
(65)
|
(81)
|
(92)
|
(97)
|
(97)
|
(88)
|
(91)
|
(94)
|
(97)
|
(106)
|
(112)
|
(104)
|
(93)
|
(84)
|
(83)
|
(67)
|
(76)
|
(77)
|
|
Selling, General & Administrative |
(9)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(14)
|
(14)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
(21)
|
(26)
|
(30)
|
(36)
|
(42)
|
(49)
|
(48)
|
(43)
|
(36)
|
(29)
|
(27)
|
(26)
|
(26)
|
|
Research & Development |
(26)
|
(27)
|
(33)
|
(36)
|
(36)
|
(37)
|
(34)
|
(34)
|
(39)
|
(49)
|
(66)
|
(77)
|
(80)
|
(80)
|
(67)
|
(65)
|
(64)
|
(61)
|
(65)
|
(63)
|
(57)
|
(50)
|
(48)
|
(40)
|
(41)
|
(50)
|
(51)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
Operating Income |
(34)
N/A
|
(37)
-6%
|
(42)
-14%
|
(45)
-8%
|
(45)
+0%
|
(46)
-2%
|
(43)
+6%
|
(38)
+12%
|
(41)
-10%
|
(48)
-17%
|
(63)
-31%
|
(80)
-27%
|
(85)
-6%
|
(86)
-1%
|
(79)
+8%
|
(76)
+4%
|
(76)
0%
|
(79)
-5%
|
(88)
-11%
|
(99)
-12%
|
(94)
+4%
|
(84)
+11%
|
(31)
+64%
|
(30)
+3%
|
(13)
+56%
|
2
N/A
|
27
+1 170%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||
Interest Income Expense |
2
|
2
|
2
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
(1)
|
(4)
|
(3)
|
(3)
|
(1)
|
3
|
3
|
4
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
(15)
|
(15)
|
0
|
0
|
(5)
|
(5)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
(1)
|
(0)
|
(0)
|
0
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(32)
N/A
|
(34)
-6%
|
(40)
-17%
|
(44)
-11%
|
(44)
0%
|
(45)
-1%
|
(42)
+7%
|
(36)
+13%
|
(39)
-9%
|
(47)
-18%
|
(61)
-31%
|
(79)
-30%
|
(83)
-5%
|
(85)
-1%
|
(78)
+8%
|
(74)
+5%
|
(76)
-1%
|
(79)
-5%
|
(90)
-13%
|
(103)
-15%
|
(113)
-10%
|
(102)
+10%
|
(46)
+55%
|
(27)
+42%
|
(10)
+62%
|
1
N/A
|
25
+4 134%
|
|
Net Income | ||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
|
Income from Continuing Operations |
(32)
|
(34)
|
(40)
|
(44)
|
(44)
|
(45)
|
(42)
|
(36)
|
(39)
|
(47)
|
(61)
|
(79)
|
(83)
|
(85)
|
(78)
|
(74)
|
(76)
|
(79)
|
(90)
|
(103)
|
(113)
|
(102)
|
(46)
|
(27)
|
(10)
|
(2)
|
23
|
|
Income to Minority Interest |
4
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(35)
N/A
|
(40)
-13%
|
(46)
-16%
|
(50)
-8%
|
(47)
+4%
|
(46)
+3%
|
(42)
+9%
|
(36)
+13%
|
(39)
-9%
|
(47)
-18%
|
(61)
-31%
|
(80)
-31%
|
(84)
-5%
|
(85)
-1%
|
(79)
+8%
|
(74)
+6%
|
(76)
-1%
|
(79)
-5%
|
(90)
-13%
|
(103)
-15%
|
(113)
-10%
|
(102)
+10%
|
(46)
+55%
|
(27)
+42%
|
(10)
+62%
|
(2)
+84%
|
23
N/A
|
|
EPS (Diluted) |
-2.51
N/A
|
-2.85
-14%
|
-3.21
-13%
|
-3.45
-7%
|
-3.29
+5%
|
-2.62
+20%
|
-2.6
+1%
|
-2.09
+20%
|
-2.23
-7%
|
-2.49
-12%
|
-3.35
-35%
|
-4.07
-21%
|
-4.07
N/A
|
-3.88
+5%
|
-3.52
+9%
|
-2.53
+28%
|
-2.54
0%
|
-2.46
+3%
|
-2.91
-18%
|
-3.16
-9%
|
-3.43
-9%
|
-2.85
+17%
|
-1.23
+57%
|
-0.51
+59%
|
-0.19
+63%
|
-0.03
+84%
|
0.43
N/A
|